Physician profile
Ashleigh Cates
NPI 1972161818
$1,084.26
in general payments reported to CMS, 2019-2025
16 companies · $555 in 2025
The $555 reported for 2025 was more than what 75% of Nurse Practitioner providers received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $354 · 2023: $146 · 2024: $28.62 · 2025: $555.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $712 · Education: $17.93.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $712.05 |
| Education | $17.93 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $271.99 | 2021-2023 | Xarelto |
| Tactile Systems Technology INC | $162.20 | 2021 | |
| Travere Therapeutics, INC. | $137.12 | 2025 | Filspari |
| Otsuka America Pharmaceutical, INC. | $99.43 | 2025 | Jynarque, Voyxact |
| Genzyme Corporation | $66.71 | 2025 | |
| Novo Nordisk INC | $62.88 | 2025 | Ozempic |
| Calliditas Therapeutics US INC. | $55.32 | 2025 | Tarpeyo |
| Smith+Nephew, INC. | $46.53 | 2021 | |
| Mallinckrodt Hospital Products INC. | $38.31 | 2025 | Terlivaz, Acthar |
| Silk Road Medical, INC. | $28.62 | 2024 | Enroute Transcarotid Neuroprotection System, Enroute Enflate Transcarotid Rx Balloon Dilatation Catheter, Enroute Transcarotid Stent |
| Cvrx, INC. | $24.03 | 2025 | Barostim Neo System |
| Bard Peripheral Vascular, INC. | $22.29 | 2025 | Covera |
| Hartmann USA, INC. | $19.71 | 2021 | |
| Astrazeneca Pharmaceuticals LP | $16.94 | 2025 | Farxiga |
| Medtronic, INC. | $16.44 | 2025 | Venaseal |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bayer Healthcare Pharmaceuticals INC. | $15.74 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ashleigh Cates listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.